Project Grant R01HL181061
Award Date 9/15/25
Completion Date 6/30/30
Dollars Obligated $772K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is providing $731,130 to the Children's Hospital Medical Center to conduct a study titled "Improving Medication Adherence Using an Adaptive mHealth Intervention in Adolescents with Asthma". The study aims to evaluate the effectiveness of a stepped-care mHealth intervention for improving adherence to daily inhaled corticosteroids in adolescents with asthma. The...
- This Project Grant award, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to support a mentored implementation science research program focused on improving asthma care and outcomes for children from marginalized communities. The $120,363 award, effective August 18, 2025, will fund Dr. Michelle Eakin's efforts to expand her mentoring program in patient-oriented implementation science. The project will leverage ongoing data collection...
- This Project Grant award from the National Heart Lung and Blood Institute, under the Cardiovascular Diseases Research program (CFDA 93.837), is providing $259,752 to the Icahn School of Medicine at Mount Sinai to develop and pilot test an integrated intervention for depression and asthma self-management in older adults. The key products/services being delivered include: Developing a 10-12 session integrated program that combines asthma self-management support (SAMBA) with cognitive behavioral...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $187,798 to the University of Rochester to design and pilot a community health worker (CHW) model for improving self-management and outcomes for children with persistent asthma in Rochester, NY. The project aims to use implementation science frameworks to co-design a sustainable, context-appropriate CHW model with community partners, and then evaluate the...
- The Project Grant award of $673,581 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a research project by Ochin, Inc. to assess disparities in asthma care between Latino and non-Hispanic white adults. The project aims to leverage a comprehensive dataset linking electronic health records to community-level social determinants of health data to evaluate factors underlying asthma care utilization disparities. The award runs from March 1, 2025...
- This $2,456,717 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to exploit emerging ideas in G protein-coupled receptor biology and pharmacology to treat asthma. The award supports a highly collaborative research team at Thomas Jefferson University's Sidney Kimmel Medical College to pursue three key goals: 1) identify novel targets and targeting molecules involving G protein-coupled receptor...
- The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $189,000 Project Grant under CFDA #93.837 Cardiovascular Diseases Research program to the University of Colorado-Denver. The 2-year grant, with a period of performance from September 15, 2025 to August 31, 2027, will support research to investigate the role of outdoor air pollution and environmental allergens in driving treatment response in children with acute asthma...
- This Project Grant award of $427,256 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports a randomized, controlled trial to evaluate the use of Bilevel Positive Airway Pressure (BPAP) for managing severe asthma exacerbations in children. The key objectives are to: 1) develop a consensus-based protocol for ED BPAP administration and use of other asthma therapies, 2) determine a primary outcome measure for a future multi-center trial, and 3)...
- This Project Grant award from the National Heart Lung and Blood Institute, under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), is funding a research project titled "Emulating Hypothetical Target Trials to Establish the Comparative Effectiveness of Biologics in Asthma." The $834,840 award to Brigham & Women's Hospital, a subsidiary of Partners Healthcare System, supports research to generate evidence on the comparative effectiveness of biologic...
- This federal Project Grant award from the National Institute of Nursing Research (NINR) under CFDA 93.361 - Nursing Research, will support the development and evaluation of IMAAP, an interactive mobile asthma action plan. The $441,375 award, effective July 17, 2024 through May 31, 2026, aims to create an innovative technology that leverages objective lung function assessment, symptom reporting, and personalized treatment recommendations to empower adolescents, particularly those from...